KR200373097Y1 - Jaundice treatment device with apnea monitoring - Google Patents
Jaundice treatment device with apnea monitoring Download PDFInfo
- Publication number
- KR200373097Y1 KR200373097Y1 KR20-2004-0029026U KR20040029026U KR200373097Y1 KR 200373097 Y1 KR200373097 Y1 KR 200373097Y1 KR 20040029026 U KR20040029026 U KR 20040029026U KR 200373097 Y1 KR200373097 Y1 KR 200373097Y1
- Authority
- KR
- South Korea
- Prior art keywords
- apnea
- jaundice
- newborn
- light
- jaundice treatment
- Prior art date
Links
- 206010023126 Jaundice Diseases 0.000 title claims abstract description 59
- 208000008784 apnea Diseases 0.000 title claims abstract description 53
- 238000012544 monitoring process Methods 0.000 title claims abstract description 17
- 210000003019 respiratory muscle Anatomy 0.000 claims description 22
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 8
- 229920002635 polyurethane Polymers 0.000 claims description 6
- 239000004814 polyurethane Substances 0.000 claims description 6
- 238000007599 discharging Methods 0.000 claims description 2
- 238000009434 installation Methods 0.000 claims description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 238000000034 method Methods 0.000 description 3
- 208000023504 respiratory system disease Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 206010023138 Jaundice neonatal Diseases 0.000 description 2
- 201000006346 Neonatal Jaundice Diseases 0.000 description 2
- 208000027119 bilirubin metabolic disease Diseases 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 208000036796 hyperbilirubinemia Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000001126 phototherapy Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010002977 Apnoeic attack Diseases 0.000 description 1
- 206010012713 Diaphragmatic hernia Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010037407 Pulmonary hypoplasia Diseases 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 206010008129 cerebral palsy Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000000122 hyperventilation Diseases 0.000 description 1
- 230000000870 hyperventilation Effects 0.000 description 1
- 208000006663 kernicterus Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 208000007844 respiratory distress syndrome in premature infants Diseases 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0616—Skin treatment other than tanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0654—Lamps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
Landscapes
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
본 고안은 황달치료기에 관한 것이다.The present invention relates to a jaundice treatment device.
본 고안은 신생아의 피부에 자외선이 발생하는 램프의 빛을 쏘여 황달을 치료함과 동시에 신생아의 무호흡 상태를 감시하여 무호흡에 따른 각종 질환을 사전에 예방할 수 있는 무호흡 감시기능을 가진 황달치료기를 제공하는데 있다.The present invention provides jaundice treatment device with apnea monitoring function that prevents jaundice by preventing the apnea of the newborn and at the same time by treating the jaundice with the light of a lamp that generates ultraviolet rays on the skin of the newborn. have.
Description
본 고안은 신생아의 피부에 자외선이 발생하는 램프의 빛을 쏘여 황달을 치료함과 동시에 신생아의 무호흡 상태를 감시하여 무호흡에 따른 각종 질환을 사전에 예방할 수 있는 무호흡 감시기능을 가진 황달치료기에 관한 것이다.The present invention relates to a jaundice treatment device having an apnea monitoring function that prevents jaundice by treating a jaundice by monitoring the apnea of a newborn while simultaneously treating a jaundice by radiating a light of a lamp that generates ultraviolet rays to the skin of a newborn baby. .
일반적으로 신생아 황달은 대부분 생리적 황달로 생후 4-5일에 가장 강하게 나타나며 그중 가장 강한 시기에서도 혈청 빌리루빈치는 10m/dl 전후 이다.In general, neonatal jaundice is most physiological jaundice, which is most intense at 4-5 days of age, and serum bilirubin levels are around 10 m / dl even in the strongest period.
신생아 황달이 생리적 범위를 넘는 경우에는 고 빌리루빈 혈증에서 핵 황달로 이행하며, 중병인 경우는 사망의 원인이 될 수 있으며, 사망을 피하더라도 뇌성마비를 야기시키는 비참한 결과를 초래하게 된다.Neonatal jaundice transitions from hyperbilirubinemia to nuclear jaundice, and severe illness can cause death, and avoiding death can lead to disastrous consequences of cerebral palsy.
신생아의 고빌리루빈 혈증 관리에 중요한 것은 총빌리루빈치를 정확하고 신속하게 파악하여 만약 빌리루빈수치가 높으면 광선요법에 의해 치료를 하게 된다.Important for the management of hyperbilirubinemia in newborns is the accurate and rapid identification of total bilirubin levels, if the bilirubin level is high, phototherapy is treated.
상기의 광선요법은 신생아의 피부에 400-500nm파장의 빛을 쏘여 치료하는 방법으로써, 황달치료기를 이용하여 신생아 피부에 빛을 쏘여 황달치료를 할때 신생아의 자세가 안정적이지 못하여 부주위할 경우 빛이 신생아의 눈에 쏘여 위험을 초래하게 되는 문제점을 가지고 있다.The above phototherapy is a method to shine 400-500nm wavelength light on the skin of newborn baby. When the jaundice treatment is used to treat the jaundice by shedding light on the newborn baby's skin by using jaundice therapy There is a problem in this newborn's eyes that poses a danger.
따라서 본원 출원인은 종래 황달치료기의 단점을 해소하면서 신생아때 생기는 특이적 호흡장애(무호흡증)을 감시할 수 있는 감시기능을 부가한 황달치료기를착안하기에 이르렀다.Accordingly, the present applicant has come up with a jaundice treatment device with a monitoring function that can monitor specific respiratory disorders (apneas) occurring in newborns while eliminating the disadvantages of the conventional jaundice treatment device.
신생아에게 일어나는 무호흡증에 대하여 부연하여 설명하면 다음과 같다.The apnea that occurs in newborns is explained in detail as follows.
신생아 일때 생기는 특이적 호흡장애로서, 호흡기계의 미숙성으로 인한 호흡궁박증후군(呼吸窮迫症候群), 폐의 구축학적 미숙성으로 인한 윌슨-미키티증후군, 호흡중추의 미숙성으로 인한 무호흡발작, 출생때에 태변(胎便)을 흡인하여 생기는 태변흡인증후군, 그 밖에 선천적인 호흡기계의 이상인 횡격막헤르니아나 폐저형성증등이 있다.Specific respiratory disorders occurring in newborns, including respiratory bowel syndrome due to immaturity of the respiratory system, Wilson-Mickey syndrome due to immaturity of the lungs, apnea attacks due to immaturity of the respiratory center, and birth At this time, there is a metastasis-absorbed syndrome, which is caused by the inhalation of urine, and other diaphragmatic hernias and pulmonary hypoplasia.
그중 가장 많은 질환은 태아 시기의 폐수(肺水)가 출생 후에 신속히 흡수되는 과정이 지연되는 신생아 일과성다호흡중으로서, 예후는 좋고 다호흡을 주로 한 호흡장애가 생후수일간 계속된다. 습폐(濕肺)라고도 하는데, 이것은 출생과 함께 일어나는 태외생활(胎外生活)에 대한 적응이 늦어진 적응부전증후군의 하나로 생각할 수 있다.The most common of these diseases is neonatal hyperventilation, in which fetal effluents are rapidly absorbed after birth. The prognosis is good, and respiratory disorders with multiple respirations continue for several days after birth. It is also known as eczematosis, which can be thought of as one of the symptoms of adaptive dysfunction, which has slowed the adaptation to extravagant life with birth.
이들 가운데서 가장 중요한 질환은 미숙아에게 생기는 호흡궁박증후군이며, 증상은 치아노. 다호흡. 함몰호흡(陷沒呼吸). 신음 등이다.The most important of these is respiratory distress syndrome in premature infants. The breathing. Depression breathing. Moans, etc.
생후 곧 발증하여 수시간 내에 심하게 악화된다.It develops soon after birth and worsens severely within hours.
이전에는 사망률이 높았으나 최근에는 여러가지 인공환기법의 진보에 의하여 대부분 후유증 없이 생존하게 된다.In the past, mortality was high, but recently, due to advances in various artificial ventilation methods, most of them survive without sequelae.
무호흡은 신생아에겐 아주 치명적인 손상을 줄 수 있으므로 이를 방지하기 위해서는 무호흡을 감시할 수 있는 장치가 있으면 된다.Apnea can be very damaging to newborns, so to prevent it, you need a device that can monitor apnea.
상기의 무호흡은 20초 이상 호흡하지 않을 때로 판단 되며, 무호흡이라고 판단되면 신속하게 호흡운동을 시켜서 폐의 수축, 확장에 의해 흉곽 용적 중감에 따라 일어나며 이때 복부의 움직임 및 등뒤의 늑골근육 등 호흡근의 움직임을 일어나게하여 치료를 하게 된다.The above apnea is judged not to breathe for more than 20 seconds, and if it is determined to be apnea, the respiratory movement is promptly performed by the contraction and expansion of the lungs, resulting in a decrease in the volume of the rib cage. You will be treated by getting up.
본 고안은 신생아의 황달을 치료하면서 무호흡 상태를 감시할 수 있는 황달치료기를 안출한 것으로, 황달치료와 함께 자가 진단이 불가능한 무호흡 상태를 사전에 감시하여 무호흡에 의한 장애 발생을 사전에 예방할 수 있을 뿐만 아니라, 황달치료와 무호흡상태를 각각 진료 받아야 하는 번거러움을 해소하였고, 황달치료기를 이용하여 황달치료를 할때 빛이 눈에 쏘여 위험을 초래하였던 종래 황달치료기의 문제점을 해소시킨 무호흡 감시기능을 가진 황달치료기를 제공하는데 그 목적이 있다.The present invention devised a jaundice treatment device that can monitor the apnea state while treating jaundice of the newborn, and can prevent the occurrence of disorders due to apnea by monitoring the apnea state that cannot be diagnosed with jaundice in advance. Rather, it resolved the hassle of treating jaundice treatment and apnea, and jaundice with apnea monitoring function solved the problem of conventional jaundice treatment device, which caused the danger of light stinging when using jaundice treatment. The purpose is to provide a therapeutic device.
본 고안의 다른 목적은 병원에서 황달치료기와 무호흡감시기를 각각 구비하여야 하는 불편함을 해소시켰을 뿐만 아니라, 기기 구입 사용에 따른 경제적인 손실을 줄여줄 수 있게 한 것에 그 목적이 있다.Another object of the present invention is to solve the inconvenience of having to provide jaundice treatment device and apnea monitoring period in the hospital, as well as to reduce the economic loss of using the device purchase.
도1은 본 고안에 따른 무호흡 감시기능을 가진 황달치료기의 회로 구성도.1 is a circuit diagram of a jaundice treatment device having an apnea monitoring function according to the present invention.
도2는 본 고안에 따른 무호흡 감시기능을 가진 황달치료기의 분리 구성도.Figure 2 is a separate configuration of jaundice treatment device having an apnea monitoring function according to the present invention.
도3은 본 고안의 몸체를 발췌한 단면구성도.Figure 3 is a cross-sectional view taken from the body of the present invention.
※도면의 주요 부분에 대한 부호의 설명※※ Explanation of code for main part of drawing ※
10 : 몸체 11 : 장착요부10 body 11 mounting portion
12 : 반사판 13 : 황달치료램프12: reflector 13: jaundice treatment lamp
14 : 배기공 15 : 표시부14 exhaust hole 15 display unit
15a : 알람 15b : 발광램프15a: alarm 15b: light emitting lamp
15c : 타이머 16 : 고정봉15c: timer 16: fixed rod
20 : 산란판 30 : 무호흡감시기20: scattering plate 30: apnea
31 : 호흡근감지센서지지판 32 : 지지봉31: respiratory muscle sensor support plate 32: support rod
33 : 호흡근감지센서 36 : 연결코넥터33: respiratory muscle sensor 36: connection connector
40 : 팬 50 : 신생아지지대40: fan 50: newborn support
51 : 틀 52 : 폴리우레탄패드51: frame 52: polyurethane pad
60 : 증폭기 70 : 비교기60 amplifier 70 comparator
80 : 마이컴 90 : 필터80: micom 90: filter
상기 목적을 달성하기 위한 본 고안의 구성은, 직육면체로 상부 중앙에 400-500nm의 파장을 발사하는 황달치료램프(13)가 위치하는 장착요부(11)가 형성되어 있되, 그 내면에 빛을 반사시켜 빛의 효율성을 높이는 반사판(12)이 설치되어 있고, 황달치료램프(13)가 설치된 일측벽에는 상기의 황달치료램프(13)로부터 발생한 열을 배기공(14)을 통해 외부로 배출시키는 팬(40)이 설치되어 있으며, 팬(40)이설치어 있는 쪽 상부면에는 무호흡 감시기(30)에 눕혀진 신생아의 호흡상태를 호흡근감지센서(33)에서 감지하게되면 감지된 신호가 필터(90)를 통해 증폭기(60)로 보내져 증폭되고 증폭된 신호를 비교기(70)에서 비교하여 비교된 신호가 무호흡 상태일때 그 신호를 마이컴(80)에서 인식하여 인식한 신호를 검사자가 인지할 수 있도록 표시해주는 알람(15a) 및 발광램프(15b)가 설치되어 있을 뿐 아니라, 황달 정도에 따라 그에 적합한 시간 동안 치료할 수 있도록 하는 타이머(15c)를 포함하는 표시부(15)가 형성되어 있는 몸체(10)와;The construction of the present invention for achieving the above object is a rectangular parallelepiped mounting portion 11, which is located jaundice treatment lamp 13 that emits a wavelength of 400-500nm in the center of the upper portion is formed, but reflects light on the inner surface Reflector 12 is installed to increase the efficiency of the light, and a fan for discharging the heat generated from the jaundice treatment lamp 13 to the outside through the exhaust hole 14 on one side wall where the jaundice treatment lamp 13 is installed. 40 is installed, the upper side of the fan 40 is installed when the respiratory muscle detection sensor 33 detects the breathing state of the newborn lying down on the apnea monitor 30, the detected signal filter 90 By comparing the amplified and amplified signal sent to the amplifier 60 through the comparator 70, when the compared signal is apnea, the signal is recognized by the microcomputer 80 to display the recognized signal for the examiner to recognize. Alarm 15a and luminous lamp (1 A body 10 having a display unit 15 including not only 5b) but also a timer 15c for treating for a suitable time according to jaundice;
몸체(10)의 장착요부(11) 상부에 걸쳐지도록 설치되어서 황달치료램프(13)의 빛을 산란시켜 빛이 신생아의 피부에 골고루 퍼질 수 있게 하는 산란판(20)과;A scattering plate 20 installed to cover the upper portion of the mounting recess 11 of the body 10 to scatter the light of the jaundice treatment lamp 13 so that the light can be evenly spread on the skin of the newborn baby;
신생아지지대(50)에 눕혀진 신생아가 얹혀짐과 동시에 신생아의 무호흡 상태를 감지하는 호흡근감지센서(33)가 설치되어 있고, 호흡근감지센서(33)의 연결코넥터(36)가 몸체(10)의 제어부(100)를 이루고 있는 필터(90)에 연결되며, 상기 산란판(20)에 지지되는 지지봉(32)이 설치되어 있는 호흡근감지센서지지판(31)으로 이루어진 무호흡감시기(30)와;A newborn baby lying on the newborn baby support 50 is placed at the same time a respiratory muscle sensor 33 is installed to detect the apnea state of the newborn, and the connection connector 36 of the respiratory muscle sensor 33 is connected to the body 10. An apnea sensor 30 connected to the filter 90 constituting the control unit 100 and comprising a respiratory muscle sensor support plate 31 having a support rod 32 supported on the scattering plate 20;
상기 몸체의 고정봉(16)에 고정되는 틀(51)과 상기 틀(51)의 내부에 신생아를 눕혀 놓을 수 있는 신축성을 갖는 투명의 폴리우레탄패드(52)가 형성되어 있는 신생아지지대(50)로 구성된 것을 특징으로 한다.Newborn baby support 50 is formed with a transparent polyurethane pad 52 having elasticity to lay the newborn in the frame 51 and the inside of the frame 51 fixed to the fixing rod 16 of the body (50) Characterized in that consisting of.
이하 본고안의 바람직한 실시예를 명세서에 첨부된 도면을 참조하여 보다 상세하게 설명한다.Hereinafter, exemplary embodiments of the present invention will be described in more detail with reference to the accompanying drawings.
도1은 본 고안에 따른 무호흡 감시기능을 가진 황달치료기의 회로 구성도이고, 도2는 본 고안에 따른 무호흡 감시기능을 가진 황달치료기의 분리 구성도이며,도3은 본 고안의 몸체를 발췌한 단면구성도이다.1 is a circuit diagram of a jaundice treatment device having an apnea monitoring function according to the present invention, Figure 2 is a separate configuration diagram of a jaundice treatment device having an apnea monitoring function according to the present invention, Figure 3 is an extract of the body of the present invention It is a cross-sectional block diagram.
도시된 바와 같이 본 고안의 무호흡 감시기능을 가진 황달치료기를 이용하여 신생아에게 발병한 황달을 치료할 때에는 몸체(10)의 장착요부(11)에 형성된 단턱진 부위로 삽입 위치할수 있도록 산란판(20)을 장착한다.As shown, when treating jaundice caused to the newborn by using a jaundice treatment device having an apnea monitoring function of the present invention scattering plate 20 to be inserted into the stepped portion formed in the mounting recess 11 of the body 10 To be fitted.
상기 산란판(20)이 장착된 장착요부(10)의 단턱진 부분에 무호흡감시기(30)의 호흡근감지센서지지판(31)의 지지봉(32)이 삽입 위치할수 있게 하여 상기의 무호흡감시기(30)를 장착한다.The apnea sensor 30 allows the support rod 32 of the respiratory muscle sensor sensor support plate 31 of the apnea sensor 30 to be inserted into the stepped portion of the mounting recess 10 on which the scattering plate 20 is mounted. To be fitted.
몸체(10)에 무호흡감시기(30)가 설치된 상태에서 호흡근감지센서(33)의 연결콘넥터(36)를 몸체(10)에 연결시킨다.In the state in which the apnea sensor 30 is installed on the body 10, the connection connector 36 of the respiratory muscle sensor 33 is connected to the body 10.
무호흡감시기(30)의 장착이 완료 되어지면 신생아지지대(50)를 장착한다.When the installation of the apnea monitor 30 is completed, the newborn support 50 is mounted.
신생아지지대(50)는 몸체(10)의 네모서리에 형성되여 있는 고정봉(16)에 틀(51)이 지지되어 움직임이 발생하지 않게 된다.Newborn support 50 is supported by the frame 51 is fixed to the rod 16 is formed on the four corners of the body 10 so that the movement does not occur.
고정봉(16)에 신생아지지대(50)가 장착되어진 상태에서 폴리우레탄패드(52)에 신생아를 눕히게 되고,폴리우레탄패드(52)에 신생아가 눕혀지면 상기의 폴리우레탄패드(52)가 늘어지면서 호흡근이 분포되여 있는 신생아의 등이 무호흡감시기(30)의 호흡근감지센서지지판(31)에 접촉된 상태로 이루어지며, 이때 호흡근감지센서지지판(31)에 위치하고 있는 호흡근감지센서(33)는 산란판(20)에 접촉되여 지지를 받게 된다.When the newborn support 50 is mounted on the fixing rod 16, the newborn baby is laid on the polyurethane pad 52. When the newborn baby is laid on the polyurethane pad 52, the polyurethane pad 52 is stretched. The back of the newborn with a respiratory muscle distribution is made in contact with the respiratory muscle sensor support plate 31 of the apnea sensor 30, wherein the respiratory muscle sensor 33 located in the respiratory muscle sensor support plate 31 is scattered In contact with the plate 20 is supported.
신생아지지대(50)에 의해서 호흡근감지센서지지판(31)에 황달치료 대상인 신생아를 눕혀 놓은 상태에서 무호흡 감시기능을 가진 황달치료기에 전원을 공급시킨다.The newborn baby supporter 50 supplies power to the jaundice treatment device having an apnea monitoring function in a state in which a newborn baby subject to jaundice is laid on the respiratory muscle sensor support plate 31.
전원이 공급되면 황달치료램프(13)가 발광하여 400-500nm 파장을 가지는 빛을 신생아에게 조사하게 된다.When power is supplied to the jaundice treatment lamp 13 emits light having a wavelength of 400-500nm to the newborn.
상기와 같이 조사되는 황달치료램프(13)의 빛은 장착요부(11)에 설치된 반사판에 의하여 신생아에게 집중적으로 조사되어 짐은 물론 산란판(20)에 의해 빛이 퍼져 신생아 피부에 골고루 쏘여진다.The light of the jaundice treatment lamp 13 irradiated as described above is intensively irradiated to the newborn by the reflecting plate installed in the mounting recess 11, as well as the light is spread by the scattering plate 20 and is evenly shot on the newborn skin.
상기에서와 같이 신생아의 피부에 400-500nm 파장의 빛을 쏘여줌으로서 빌리루빈 수치가 낮아져 황달치료가 가능해 진다.As described above, by releasing 400-500nm wavelength of light on the skin of a newborn, bilirubin levels are lowered, which makes it possible to treat jaundice.
황달치료시간은 신생아에 발병한 황달 정도에 따라 적정한 시간동안 치료를 하게되고, 치료시간의 측정은 표시부(15)에 위치하여 있는 타이머(15c)를 이용하게 된다.Jaundice treatment time is treated for an appropriate time depending on the degree of jaundice on the newborn, the measurement of the treatment time is to use the timer (15c) located on the display unit 15.
한편, 400-500nm 파장의 빛을 가지고 발광하는 황달치료램프(13)에서는 열이 발생하게 되는데, 상기의 황달치료램프(13)로부터 발생한 열은 팬(40)의 작동에 의해 배기공(14)을 통해 외부로 배출되어지게 된다.On the other hand, heat is generated in the jaundice treatment lamp 13 emitting light with light having a wavelength of 400-500 nm, and heat generated from the jaundice treatment lamp 13 is exhausted by the operation of the fan 40. It is discharged to the outside through.
위에서 설명한 바와 같이 무호흡 감시기능을 가진 황달치료기를 이용하여 신생아의 황달을 치료할때 신생아에게 치명적인 장애를 이르킬 수 있는 무호흡 상태를 감시하여 무호흡에 의한 장애요인을 미연에 방지하게 된다.As described above, when treating jaundice of a newborn baby using a jaundice treatment device having an apnea monitoring function, an obstructive condition that can cause a fatal disorder to a newborn is monitored to prevent obstacles caused by apnea.
신생아의 무호흡 상태 감지는 황달치료를 위하여 신생아지지대(50)의 의해서 무호흡감시기(30)의 호흡근감지센서지지판(31)에 눕혀져 있는 신생아의 등에 분포되어 있는 호흡근의 상태를 호흡근감지센서(33)가 감지하여 무호흡이 20초 이상 지속되면 무호흡 상태로 판단하여 응급 조치를 할 수 있게 한다.The detection of apnea of the newborn is performed by the respiratory muscle sensor 33 to detect the state of the respiratory muscles distributed on the back of the newborn baby lying on the respiratory muscle sensor support plate 31 of the apnea monitor 30 by the neonatal support 50 for the treatment of jaundice. If the apnea lasts more than 20 seconds, it is determined that the apnea state allows emergency measures.
상기 호흡근감지센서(33)에 의해 감지된 신호를 검사자가 인지할 수 있는 것은 도1에서와 같이 호흡근감지센서(33)에 의해 감지된 신호가 제어부(100)의 필터(90)를 통해 증폭기(60)로 보내져 증폭되고 증폭된 신호를 비교기(70)에서 비교하여 비교된 신호가 무호흡 상태 일때 그 신호를 마이컴(80)에서 인식하게 된다.The inspector can recognize the signal detected by the respiratory muscle sensor 33 as shown in Figure 1 the signal detected by the respiratory muscle sensor 33 through the filter 90 of the control unit 100 amplifier ( 60 and the amplified and amplified signal is compared in the comparator 70 and when the compared signal is apnea, the signal is recognized by the microcomputer 80.
상기의 과정을 통해 마이컴(80)에 인식된 신호가 무호흡 상태(약 20초 이상 호흡정지)임을 인식하게 되면, 인식된 신호에 의하여 표시부(15)의 알람(15a)과 발광램프(15b)가 동시에 작동하여 신생아의 호흡 상태가 양호하지 못하고 무호흡 상태임을 검사자가 쉽게 판단할 수 있게 하였다.When the signal recognized by the microcomputer 80 is recognized as the apnea state (respiration stop for about 20 seconds or more) through the above process, the alarm 15a and the light emitting lamp 15b of the display unit 15 are detected by the recognized signal. At the same time, it was possible for the examiner to easily determine that the newborn was not breathing well and was not apnea.
상기와 같이 표시부(15)의 알람(15a)과 발광램프(15b)를 통해 신생아의 호흡이 무호흡 상태임이 판단되면 검사자는 치료를 위한 다음 조치를 신속하게 취하여 무호흡에 따른 신생아의 각종 장애를 사전에 예방할 수 있게 되는 것이다.As described above, when it is determined that the breathing of the newborn is apnea through the alarm 15a and the light emitting lamp 15b of the display unit 15, the inspector promptly takes the following measures for treatment to preemptively diagnose various disorders of the newborn due to the apnea. It can be prevented.
상기된 바와 같이 본 고안의 무호흡 감시기능을 가진 황달치료기는,Jaundice treatment device having an apnea monitoring function of the present invention, as described above,
첫째, 신생아에게 발병된 황달치료를 하면서 자가 진단이 불가능한 무호흡에 의한 장애 발생을 사전에 예방할 수 있을 뿐만 아니라, 황달치료와 무호흡상태를 각각 진료 받아야 하는 번거러움을 해소하였고, 황달치료기를 이용하여 황달치료를 할때 빛이 눈에 쏘여 위험을 초래하였던 종래 황달치료기가 가지고 있던 문제점을 해소시킨 것에 그 효과가 있다.First, the treatment of jaundice in newborns prevents the occurrence of disorders due to apnea that is not self-diagnosed, and eliminates the hassles of treating jaundice and apnea, and using jaundice therapy. The effect is that it solves the problem that the conventional jaundice treatment device had a danger of light sting in eyes when doing.
둘째, 병원에서 황달치료기와 무호흡감시기를 각각 구비하여야 하는 불편함을 해소시켰을 뿐만 아니라, 기기 구입 사용에 따른 경제적인 손실을 줄여줄 수 있는 효과를 가지고 있다.셋째, 무호흡감시기에 발생한 오염물질을 쉽게 세척할 수 있는 잇점을 가지고 있는 것이다.Second, in addition to eliminating the inconvenience of having jaundice treatment devices and apnea monitors in hospitals, it also has the effect of reducing economic losses associated with the purchase and use of devices. It has the benefit of being washable.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20-2004-0029026U KR200373097Y1 (en) | 2004-10-13 | 2004-10-13 | Jaundice treatment device with apnea monitoring |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20-2004-0029026U KR200373097Y1 (en) | 2004-10-13 | 2004-10-13 | Jaundice treatment device with apnea monitoring |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR200373097Y1 true KR200373097Y1 (en) | 2005-01-15 |
Family
ID=49444516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR20-2004-0029026U KR200373097Y1 (en) | 2004-10-13 | 2004-10-13 | Jaundice treatment device with apnea monitoring |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR200373097Y1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220122535A (en) | 2021-02-25 | 2022-09-02 | (주)비스토스 | Incubator with the ability to awaken premature babies with apnea |
| KR20220122536A (en) | 2021-02-25 | 2022-09-02 | (주)비스토스 | Incubator with posture change function for premature babies |
| CN115105031A (en) * | 2022-06-27 | 2022-09-27 | 韩艳梅 | Jaundice therapeutic instrument's management and control system |
-
2004
- 2004-10-13 KR KR20-2004-0029026U patent/KR200373097Y1/en not_active IP Right Cessation
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220122535A (en) | 2021-02-25 | 2022-09-02 | (주)비스토스 | Incubator with the ability to awaken premature babies with apnea |
| KR20220122536A (en) | 2021-02-25 | 2022-09-02 | (주)비스토스 | Incubator with posture change function for premature babies |
| CN115105031A (en) * | 2022-06-27 | 2022-09-27 | 韩艳梅 | Jaundice therapeutic instrument's management and control system |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Freudigman et al. | Infant sleep during the first postnatal day: an opportunity for assessment of vulnerability | |
| Blumberg et al. | Ultrasonic vocalizations by rat pups in the cold: an acoustic by-product of laryngeal braking? | |
| JP6487071B2 (en) | Phototherapy device with integrated urine collector and sensor that allows side effects to be reduced | |
| Claure et al. | Automated adjustment of inspired oxygen in preterm infants with frequent fluctuations in oxygenation: a pilot clinical trial | |
| Gaultier | Cardiorespiratory adaptation during sleep in infants and children | |
| US6135117A (en) | Non-ocular circadian clock resetting in humans | |
| Ozawa et al. | Effect of procedure light on the physiological responses of preterm infants | |
| US20170333729A1 (en) | Sleep mask that incorporates light to regulate uterine contractions | |
| US20150141762A1 (en) | Apparatus and method for the detection of the body position while sleeping | |
| Grunau et al. | Pain reactivity in former extremely low birth weight infants at corrected age 8 months compared with term born controls | |
| Sanders et al. | Diagnosis of Sleep-Disordered Breathing by Half-Night Polysomnography1-4 | |
| Barnaś et al. | Diurnal and nocturnal serum melatonin concentrations after treatment with continuous positive airway pressure in patients with obstructive sleep apnea | |
| Passi et al. | Electrical grounding improves vagal tone in preterm infants | |
| CN103462597A (en) | Method and device for preventing obstructive sleep sudden death based on intelligent mobile phone control | |
| Noonan et al. | Freshwater submersion injuries in children: a retrospective review of seventy-five hospitalized patients | |
| KR200373097Y1 (en) | Jaundice treatment device with apnea monitoring | |
| CN209884605U (en) | Neonatal jaundice blue light treatment case | |
| Glotzbach et al. | Light variability in the modern neonatal nursery: chronobiologic issues | |
| Tomori et al. | Resuscitation and auto resuscitation by airway reflexes in animals | |
| Mateer et al. | Continuous pulse oximetry during emergency endotracheal intubation | |
| CN117338262A (en) | Patient vital sign detection device for off-bed alarm and use method thereof | |
| Maxwell et al. | Monitoring the resuscitation of preterm infants in the delivery room using pulse oximetry | |
| KR102415948B1 (en) | Apparatus for bladder function monitoring based on physiological information | |
| Farrell et al. | Ultrasonic vocalizations by rat pups after adrenergic manipulations of brown fat metabolism. | |
| CN205107620U (en) | Human sleep monitor device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REGI | Registration of establishment | ||
| T201 | Request for technology evaluation of utility model | ||
| T701 | Written decision to grant on technology evaluation | ||
| FPAY | Annual fee payment |
Payment date: 20071231 Year of fee payment: 4 |
|
| LAPS | Lapse due to unpaid annual fee |